Mycoplasma hyponeumoniae

Respiratory infection caused by Mycoplasma hyopneumoniae has been a well-known feature of swine production for decades.


Its worldwide presence means that it has a substantial economic impact on most swine herds. Let’s take a look at the present and future perspectives from some of the main M.hyo specialists.

Videos & Publications about Mycoplasma hyopneumoniae

  • The assessment of pulmonary lesions compatible with Enzootic Pneumonia at the slaughterhouse is one of the techniques of reference for assessing the incidence of this disease in porcine farms and it i

  • The aim of this publication was to show the effect of Mhyosphere® PCV ID vaccination in growth performance of vaccinated pigs.

  • In the following video, we will see the efficacy evaluation of Mhyosphere® PCV ID under field conditions, in terms of lung lesion and reduction of PCV2 viremia.

  • This publication explains the efficacy of Mhyosphere® PCV ID in terms of duration of immunity.

  • In the following video, we will see the efficacy in terms of onset of immunity of Mhyosphere® PCV ID.

  • MHYOSPHERE® PCV ID is the first and only vaccine based on a recombinant Mycoplasama hyopneumoniae (M. hyo) strain, called Nexyhon. This strain expresses the capsid proteins of Por

  • Quim Segalés talks about the relation between the use of antibiotics and the efficacy of Mycoplasma hyopneumoniae vaccines.

  • Alex Eggen explains how to assess the efficacy of Mycoplasma hyopneumoniea vaccines in the field.

  • Control of M. hyopneumoniae infections in pig herds can be accomplished by optimizing management and biosecurity practices and housing conditions (Maes et al., 2008). However, these